Abnormalities in the growth hormone axis and risk of nonalcoholic steatohepatitis: active player or innocent bystander?

Affiliations

¹ Division of Gastroenterology, Hepatology, and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio. Electronic address: Stavra.xanthakos@cchmc.org.
² Division of Endocrinology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio.
³ Section of Pediatric Endocrinology and Diabetes, Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.

Editorial

Stavra A Xanthakos et al. J Pediatr. 2014 Jul.

. 2014 Jul;165(1):12-4.

doi: 10.1016/j.jpeds.2014.03.031. Epub 2014 May 3.

¹ Division of Gastroenterology, Hepatology, and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio. Electronic address: Stavra.xanthakos@cchmc.org.
² Division of Endocrinology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio.
³ Section of Pediatric Endocrinology and Diabetes, Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.

No abstract available

Comment on

Insulin-like growth factor-I and -II levels are associated with the progression of nonalcoholic fatty liver disease in obese children.
Cianfarani S, Inzaghi E, Alisi A, Germani D, Puglianiello A, Nobili V. Cianfarani S, et al. J Pediatr. 2014 Jul;165(1):92-8. doi: 10.1016/j.jpeds.2014.01.052. Epub 2014 Mar 5. J Pediatr. 2014. PMID: 24607243